These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37296188)

  • 1. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
    Furgała A; Ciesielczyk K; Przybylska-Feluś M; Jabłoński K; Gil K; Zwolińska-Wcisło M
    Sci Rep; 2023 Jun; 13(1):9420. PubMed ID: 37296188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients.
    Mazur M; Furgała A; Jabłoński K; Mach T; Thor P
    Med Sci Monit; 2012 Aug; 18(8):CR493-499. PubMed ID: 22847198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal and distal gut hormone secretion in irritable bowel syndrome.
    Van Der Veek PP; Biemond I; Masclee AA
    Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
    van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
    Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S; Mahayosnond A; Kullavanijaya P
    Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibited postprandial retrograde cyclic motor pattern in the distal colon of patients with diarrhea-predominant irritable bowel syndrome.
    Wiklendt L; Mohd Rosli R; Kumar R; Paskaranandavadivel N; Bampton PA; Maslen L; Costa M; Brookes SJ; O'Grady G; Dinning PG
    Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G62-G79. PubMed ID: 37162180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
    Simrén M; Abrahamsson H; Björnsson ES
    Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of gut hormones in irritable bowel syndrome].
    Morise K; Furusawa A; Yamamoto H; Saito H
    Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals.
    Monem SMA; Elbadrawy EG; Shalaby SM; Hendawy DM; Hassan SM; Almonem NA
    J Med Life; 2022 Dec; 15(12):1525-1531. PubMed ID: 36762339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
    Roth B; Myllyvainio J; D'Amato M; Larsson E; Ohlsson B
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are gut peptides responsible for the irritable bowel syndrome (IBS)?
    Sjölund K; Ekman R
    Scand J Gastroenterol Suppl; 1987; 130():15-20. PubMed ID: 3477012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Buckley MM; O'Brien R; Buckley JM; O'Malley D
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13684. PubMed ID: 31311066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients.
    Mazur M; Furgała A; Jabłoński K; Madroszkiewicz D; Ciećko-Michalska I; Bugajski A; Thor PJ
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():131-9. PubMed ID: 17901589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between preprandial and postprandial rectal sensory and motor abnormalities in IBS.
    Törnblom H; Van Oudenhove L; Tack J; Simrén M
    Gut; 2014 Sep; 63(9):1441-9. PubMed ID: 24142965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.